logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Multilevel analysis of regulatory mechanism disorders as a principle of choice for individual antihypertensive therapy in patients with hypertension (Part II). Optimization of antihypertensive therapy choice taking into account the multilevel analysis of violations in regulatory mechanisms of arterial blood

[Internal diseases]
Lyudmila Yeliseyeva; Natalya Anatolyevna Samorodskaya;

Aim: optimization of the individual antihypertensive therapy (AHT) choice in patients with hypertension (H) taking into account the violation analysis of arterial blood pressure (AP) regulation system. This study has included 277 patients with hypertension degree II at the age of 58.6±6.4 years. As a form of monotherapy it was administered: nebivolol, lisinopril, losartan, indapamid, amlodipin, and non-fixed combination of lisinopril and indapamid. Changes of indicators were studied at the allocated levels: integrative, vegetative support, organ, initially peripheral levels in 6 months of AGT. Changes at peripheral and organ levels were quite various and postponed, from 3 to 6 months. And this fact demonstrated that it was impossible to apply them as a chosen initial therapy and as an operative express correction; at integrative and vegetative levels: we noticed some signs of regulative and adaptive status (RAS) in sympathicotonic (St) type of vegetative regulation on treatment with nebivolol, lisinopril, losartan, in parasympatheticotonic(Ps) type in treatment with amlodipin, indapamide; in mixed (Mi) type in mixed therapy with indapamide and lisinopril. Integrative and vegetative levels of AP regulative system showed objective quantitative characteristics of functional status of the body, so this allows to improve approach to arterial hypertension therapy.

Download

References:
1. Mancia G., Fagard R., Narkiewicz K. [et al.]. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31(7):1281- 1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
2. Karpov Ju. A. Novye rekomendacii po arterial’noj gipertenzii RMOAG/VNOK 2010: Voprosy kombinirovannoj terapii. RMZh. – Russian medical journal. 2010;18(22):1290-1297. (In Russ.).
3. Adasheva T. V., Samorukova E. I., Zadionchenko V. S., Nesterenko O. I. Na chem osnovyvaetsja optimal’nyj vybor antigipertenzivnoj terapii: na specifi cheskih dlja klassa jeff ektah ili osobyh svojstvah preparata. Ter. arhiv. – Therapeutic Archive. 2013;9:102- 106. (In Russ.).
4. Shal’nova S. A., Kukushkin S., Manoshkina E., Timofeeva T. Arterial’naja gipertenzija i priverzhennost’ terapii. Vrach. – Doctor. 2009;12:39-42. (In Russ.).
5. Strjuk R. I., Golikova A. A., Brytkova Ja. V., Abdurazakova A. M. Vegetativnyj status u zhenshhin s gipertonicheskoj bolezn’ju v perimenopauze i pri beremennosti. Kardiologija. – Cardiology. 2012;52(7):36-41. (In Russ.).
6. Lucini D., Solaro N., Pagani M. May autonomic indices from cardiovascular variability help identify hypertension? J. Hypertens. 2014;32(2):363-373. https://doi.org/10.1097/HJH.0000000000000020
7. Sala R., Malacarne M., Solaro N., Pagani M., Lucini D. A Composite Autonomic Index as Unitary Metric for Heart Rate Variability: A Proof of Concept. Eur. J. Clin. Invest. 2017;47(3):241-249. https://doi.org/10.1111/eci.12730
8. Pokrovskij V. M. Serdechno-dyhatel’nyj sinhronizm v ocenke reguljatorno-adaptivnyh vozmozhnostej organizma. Krasnodar: Kuban’-Kniga, 2010. (In Russ.).
9. Dzhaiani N. A. Ingibitory APF – lidery v lechenii AG. Fokus na lizinopril. RMZh. – Russian medical journal. 2013;10(3):154-157. (In Russ.).
10. Morozova T. E., Andrushhishina T. B. Sovremennye aspekty farmakoterapii arterial’noj gipertenzii: vozmozhnosti amlodipina. Lechashhij vrach. – Attending doctor. 2013;2:7-13. (In Russ.).
11. Gurfi nkel’ Yu. I., Kudutkina M. I., Parfenova L. M., Orlov V. A. Osobennosti mikrotsirkulyatsii u bol’nykh s khronicheskoy serdechnoy nedostatochnost’yu na fone lecheniya ingibitorami APF i diuretikami. Rossiyskiy kardiologicheskiy zhurnal. – Russian Journal of Cardiology. 2011;88(2):43-48. (In Russ.). https://doi.org/10.15829/1560-4071-2011-2-43-48
12. Nizhegorodtsev M. YU., Teplyakov A. T., Kuznetsova A. V., Lukinov A. V., Goryutskiy V. N. Otsenka vliyaniya blokatora AT1-retseptorov angiotenzina II Valsartana na regress postinfarktnogo remodelirovaniya levogo zheludochka, narusheniye mikrotsirkulyatsii i insulinorezistentnosti u bol’nykh IBS, otyagoshchennoy sakharnym diabetom 2 tipa. Sibirskiy meditsinskiy zhurnal. – Siberian medical journal. 2009;1:6-12. (In Russ.). https://doi.org/10.24412/FetRXlEgymc

Keywords: blood pressure, evaluation of treatment effectiveness for primary arterial hypertension


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy